Schedule c 
BIOLOGICAL PRODUCTS AND special PRODUCTS 
Y. NARENDRA 
M.PHARMACY, 
(PHARMACEUTICS)
1.Sera 
2.Solution of serum proteins intended for injection. 
3.Vaccins for parental injections 
. 
4.Toxins. 
5.Antigen. 
6.Antitoxins. 
7.neo_arsphenamine and analogous substances used for the 
specific treatment of infective diseases. 
8.Insulin
9.pitutiary(posterior lobe)extract. 
10.Adrenalin and solutions of salts of adrenaline, 
11.Antibiotics and preparations thereof in form to be administered 
parenterally. 
12.Any other preparation which is meant for parentral administration 
as such or after being made up with solvent or medium or any other 
sterile product and which 
(a)Requires to be in a refrigirator:or 
(b)Does not require to be in a refrigerator. 
13.Steriized surgical ligature and sterilized surgical suture. 
14.bacteriophages. 
15.Opthalmic preparations . 
16.Sterile disposable for single use only.
SPECIAL PROVISIONS RELATING TO BIOLOGICAL AND 
OTHER SPECIAL PRODUCTS 
NAME OF SUBSTANCE; 
if any substance specified in schedule C is advertised or sold as a sold as a 
proprietary medicine or is contained in a medicine so advertised or sold, the proper 
name of the substance shell appear on the label in the manner prescribed in this part. 
CONTAINER; 
no substance specified in schedule C shall be sold or offered for sale unless 
it has been sealed in a previously sterilized container made of glass or any other 
suitable material approved for the purpose by the licensing authority appointed under 
rule 21 ,
LABELLING OF MEDICAL DEVICES: 
The labelling of medical devices shall conform to the Indian standards 
specifications laid down from time to time by the bureau of Indian standards in addition to 
any other requirement prescribed under the sais rules . 
PROHIBITION OF SALE OF SUBSTANCE AFTER PRESCRIBED DATE: 
No person shall sell, or exhibit for sale any substances specified in schedule C 
after the date recorded on the container, label or wrapper as the date up to which the 
substance may be expected to retain a potency not less then, not to acquire a toxicity 
greater then that required or permitted by the prescribed test as the case may be 
STANDARDS: 
every substance specified in schedules C and C(1) intended for sale shall 
conform with the standards of strength, quality, and purity specified in these in these rules 
and in schedule applied to samples taken from the final product after every 
manufacturing process has been completed.
TEST FOR STERNGTH ANA QUALITY: 
TEST FOR STERILITY ; 
TEST FOR PRESCENCE OF LIVING AEROBIC OR ANAEROBIC BACTERIA; 
APPLICATION TEST FOR STERILITY; 
a)To samples taken from each of the substance before the operation filling and sealing the 
containers in which it to be issued has commenced except preparations, which after being 
sealed in the containers are to be sterilized by heat ,in a manner satisfactory to the licensing 
authority 
b)To the contents of sample containers when ready for use. 
METHOD OF TESTING; 
1)If at this examination no growth of micro-organisms is found in any tube ,the sample 
may be treated as having passed the test . 
2)If at this examination a growth of micro-organisms is visible ,further samples may be 
taken and the tests may be repeated on the further samples taken.
 TEST FOR FREEDOM FROM ABNORMAL TOXICITY; 
 As per current edition of Indian pharmacopeia in the case 
of each batch of the serum tested by the license or by an 
institution approved by the licensing authority for the 
purpose of carrying out the test on its behalf. 
 TEST FOR PYROGENS; 
 Solution of substances intended for parentral 
administration in large volumes shall be pyrogen free and 
tested for pyrogens .if water or any other aqueous solvent is 
supplied along with the substances for preparing such 
solutions ,it shall also be pyrogens free and tested for 
pyrogens

Schedule c

  • 1.
    Schedule c BIOLOGICALPRODUCTS AND special PRODUCTS Y. NARENDRA M.PHARMACY, (PHARMACEUTICS)
  • 2.
    1.Sera 2.Solution ofserum proteins intended for injection. 3.Vaccins for parental injections . 4.Toxins. 5.Antigen. 6.Antitoxins. 7.neo_arsphenamine and analogous substances used for the specific treatment of infective diseases. 8.Insulin
  • 3.
    9.pitutiary(posterior lobe)extract. 10.Adrenalinand solutions of salts of adrenaline, 11.Antibiotics and preparations thereof in form to be administered parenterally. 12.Any other preparation which is meant for parentral administration as such or after being made up with solvent or medium or any other sterile product and which (a)Requires to be in a refrigirator:or (b)Does not require to be in a refrigerator. 13.Steriized surgical ligature and sterilized surgical suture. 14.bacteriophages. 15.Opthalmic preparations . 16.Sterile disposable for single use only.
  • 4.
    SPECIAL PROVISIONS RELATINGTO BIOLOGICAL AND OTHER SPECIAL PRODUCTS NAME OF SUBSTANCE; if any substance specified in schedule C is advertised or sold as a sold as a proprietary medicine or is contained in a medicine so advertised or sold, the proper name of the substance shell appear on the label in the manner prescribed in this part. CONTAINER; no substance specified in schedule C shall be sold or offered for sale unless it has been sealed in a previously sterilized container made of glass or any other suitable material approved for the purpose by the licensing authority appointed under rule 21 ,
  • 5.
    LABELLING OF MEDICALDEVICES: The labelling of medical devices shall conform to the Indian standards specifications laid down from time to time by the bureau of Indian standards in addition to any other requirement prescribed under the sais rules . PROHIBITION OF SALE OF SUBSTANCE AFTER PRESCRIBED DATE: No person shall sell, or exhibit for sale any substances specified in schedule C after the date recorded on the container, label or wrapper as the date up to which the substance may be expected to retain a potency not less then, not to acquire a toxicity greater then that required or permitted by the prescribed test as the case may be STANDARDS: every substance specified in schedules C and C(1) intended for sale shall conform with the standards of strength, quality, and purity specified in these in these rules and in schedule applied to samples taken from the final product after every manufacturing process has been completed.
  • 6.
    TEST FOR STERNGTHANA QUALITY: TEST FOR STERILITY ; TEST FOR PRESCENCE OF LIVING AEROBIC OR ANAEROBIC BACTERIA; APPLICATION TEST FOR STERILITY; a)To samples taken from each of the substance before the operation filling and sealing the containers in which it to be issued has commenced except preparations, which after being sealed in the containers are to be sterilized by heat ,in a manner satisfactory to the licensing authority b)To the contents of sample containers when ready for use. METHOD OF TESTING; 1)If at this examination no growth of micro-organisms is found in any tube ,the sample may be treated as having passed the test . 2)If at this examination a growth of micro-organisms is visible ,further samples may be taken and the tests may be repeated on the further samples taken.
  • 7.
     TEST FORFREEDOM FROM ABNORMAL TOXICITY;  As per current edition of Indian pharmacopeia in the case of each batch of the serum tested by the license or by an institution approved by the licensing authority for the purpose of carrying out the test on its behalf.  TEST FOR PYROGENS;  Solution of substances intended for parentral administration in large volumes shall be pyrogen free and tested for pyrogens .if water or any other aqueous solvent is supplied along with the substances for preparing such solutions ,it shall also be pyrogens free and tested for pyrogens